Supplemental File: Non-cutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy
Published: 23 February 2023| Version 2 | DOI: 10.17632/mrdyhdh78k.2
Contributors:
Maria Asdourian, Ted Jacoby, Nishi Shah, Tracey Otto, Leah Thompson, Edward Christopher Dee, Kerry Reynolds, Yevgeniy Semenov, Steven ChenDescription
These supplemental files include additional details on study methodology, supplemental figures (Kaplan-Meier curves), as well as supplemental tables I and II.
Files
Categories
Dermatology, Cancer Immunotherapy, Drug Adverse Reactions, Survival Analysis, Medical Oncology